MedPath
HSA Approval

COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP

SIN06281P

COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP

COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP

June 11, 1991

LUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED

LUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantLUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED
Licence HolderLUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05XA31

electrolytes in combination with other drugs

Manufacturer Information

LUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED

PT OTSUKA INDONESIA

THAI OTSUKA PHARMACEUTICAL CO LTD

Active Ingredients

SODIUM CHLORIDE

0.6 g/100 ml

Sodium chloride

CALCIUM CHLORIDE

0.027 g/100 ml

Calcium chloride

LACTIC ACID

0.24 ml/100 ml

Lactic acid

POTASSIUM CHLORIDE

0.04 g/100 ml

Potassium chloride

SODIUM HYDROXIDE

0.115 g/100 ml

Sodium hydroxide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP - HSA Approval | MedPath